Officials said that British residents who received the AstraZeneca vaccination had blood clots that were beyond initial imagination, because German officials advised to avoid using the brand during booster injections.
The British drug and healthcare products regulator announced on Thursday that it has recorded 30 cases of blood clots, which is a big difference from the previous five cases.
These include 22 reports on cerebral venous sinus thrombosis, an extremely rare brain disease, and 8 reports on coagulation events related to low platelets shortly after the controversial poke.
Although there are reports of deaths in other parts of Europe, more than a dozen countries have stopped using AstraZeneca̵
Of the patients who received BioNTech and Pfizer jabs, the UK has not yet received a single report of such blood clots.
Health officials still say that the benefits of fighting COVID-19 with AstraZeneca far outweigh the risks, noting that so far, 18.1 million doses have been provided in the UK for these 30 cases.
MHRA said: “Invited to continue vaccination.”
However, in Germany, officials on Thursday advised anyone who had taken the AstraZeneca jab to switch to another manufacturer for a second shot.
US News Service International reported that the country has restricted the use of people over the age of 60-the permanent vaccination committee, STIKO, also advises people under 60 not to use it.
UPI said, “Until appropriate data is available, STIKO recommends that people under 60 should receive a second dose of AstraZeneca vaccine instead of a second dose of AstraZeneca vaccine within 12 weeks after the first vaccination.”
To date, Germany has recorded 31 rare cases of brain clots, including 9 deaths. Almost all of them are women under the age of 60.
The United States has also approved three other vaccines, namely Moderna, Pfizer/BioNTech and Johnson & Johnson.
In the United States, White House medical adviser Dr. Anthony Fauci said on Thursday that even if the gun is approved by federal regulators, it may not need AstraZeneca’s coronavirus vaccine.